Ocular Involvement in the Histiocytoses: A Literature Review with an Illustrative Case Series.

Jennifer Kim, Laura R Steeples, Nicholas P Jones

Journal: Ocular immunology and inflammation 2022;30(3):600-614

PMID: 34637661

Abstract

PURPOSE

To describe and illustrate recent reclassification and clinical descriptions of the histiocytoses, diagnosis and management, and effects on the eye and adnexae.

PATIENTS AND METHODS

Literature review with an illustrative case series of seven patients with histiocytosis and ophthalmic involvement from a single tertiary centre.

RESULTS

Skin lesions with signs including eyelid mass, orbital bone destruction, bizarre keratic precipitates, limbal or iris mass, haemorrhagic anterior uveitis, subretinal lesions of uncertain etiology, ischaemic retinopathy, optic neuropathy, and apparent steroid-resistant inflammations should be comprehensively investigated.

CONCLUSIONS

Ophthalmic involvement in histiocytosis is rare. Clinical manifestations vary from limited single-organ disease to lethal systemic infiltration or malignancy. Radiology may identify lesions for biopsy. Histology with appropriate markers is essential. Oncology advice may be required.

Address: Manchester Royal Eye Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.; Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.; Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.